| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |